ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.707,28
-0,87%
S&P 500
5.266,95
0,00%
US Dollar vs BRL
5,2038
0,00%
Bitcoin
68.276,69
1,03%
Brent Oil
82,585
-0,95%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Accelerated Pharma (MM) (ACCP)

  7. Accelerated Pharma (MM) (ACCP) Notícias

ACCP

ACCELERATED PHARMA, INC. (ACCP)

Accelerated Pharma (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACCP
DataHoraFonteTítuloCódigoCompanhia
22/04/202013:45Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACCPAccelerated Pharma (MM)
06/02/202011:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACCPAccelerated Pharma (MM)
05/02/202013:33Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACCPAccelerated Pharma (MM)
08/11/201908:00Edgar (US Regulatory)Effectiveness Order (effect)NASDAQ:ACCPAccelerated Pharma (MM)
06/11/201908:06Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ACCPAccelerated Pharma (MM)
22/10/201807:06Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ACCPAccelerated Pharma (MM)
23/08/201713:10Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:ACCPAccelerated Pharma (MM)
18/04/201715:22Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:ACCPAccelerated Pharma (MM)
04/02/201012:00PR Newswire (US)Access Pharmaceuticals Initiates Program Applying Cobalamin Platform to siRNA Drug DeliveryNASDAQ:ACCP
02/02/201018:22PR Newswire (US)Access Pharmaceuticals Announces Closing of $6.3 Million in Registered Direct OfferingNASDAQ:ACCP
22/01/201012:29PR Newswire (US)Access Pharmaceuticals Raises $6.3 Million In Registered Direct OfferingNASDAQ:ACCP
19/01/201012:00PR Newswire (US)Access Pharmaceutical's Cobalamin Oral Insulin Achieves Greater Than 80% Oral Bioavailability In Preclinical ModelsNASDAQ:ACCP
07/01/201011:30PR Newswire (US)Access Pharmaceuticals Announces Completion of ProLindac Monotherapy Trial and Initiation of Combination StudyNASDAQ:ACCP
06/01/201012:00PR Newswire (US)Access Pharmaceuticals To Present at OneMedPlace Forum 2010NASDAQ:ACCP
15/12/200912:00PR Newswire (US)Access Pharmaceuticals Appoints Sales and Marketing ExecutiveNASDAQ:ACCP
03/12/200915:48PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in EuropeNASDAQ:ACCP
17/11/200912:00PR Newswire (US)ChangeWave Issues Buy Recommendation on Access PharmaceuticalsNASDAQ:ACCP
11/11/200912:00PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North AmericaNASDAQ:ACCP
15/10/200909:00PR Newswire (US)Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians FeedbackNASDAQ:ACCP
06/10/200909:00PR Newswire (US)Access Pharmaceuticals Signs eMarketing Agreement With iMedicor For MuGard(TM)NASDAQ:ACCP
11/09/200910:00PR Newswire (US)Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United StatesNASDAQ:ACCP
10/09/200910:00PR Newswire (US)Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development PlanNASDAQ:ACCP
01/09/200910:00PR Newswire (US)Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare ConferenceNASDAQ:ACCP
03/08/200907:00PR Newswire (US)Access Pharmaceuticals Provides Update on ProLindac Clinical Development ProgramNASDAQ:ACCP
29/07/200910:00PR Newswire (US)Access Pharmaceuticals Announces New MuGard Commercial Strategy in North AmericaNASDAQ:ACCP
27/07/200910:00PR Newswire (US)Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharmNASDAQ:ACCP
23/07/200910:00PR Newswire (US)MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer PatientsNASDAQ:ACCP
22/07/200912:08PR Newswire (US)UPDATE: Access Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock ConferenceNASDAQ:ACCP
22/07/200910:00PR Newswire (US)Access Pharmaceuticals to Present at Jessup & Lamont 2009 Growth Stock ConferenceNASDAQ:ACCP
13/07/200909:30PR Newswire (US)Jesup & Lamont Announces Presenting LifeTech Companies and Former FDA Commissioner at Annual Growth Stock & National Sales ConfeNASDAQ:ACCP
 Apresentando as notícias mais relevantes sobre:NASDAQ:ACCP

Seu Histórico Recente

BIT
P1OS95
BNP Paribas Issuance
BIT
P126G5
BNP PARIBAS ISSUANCE
COIN
WLDUSD
Worldcoin
BIT
F08492
Vontobel Financial Produ...
USOTC
JPXCF
Japan Excellent (PK)
EU
CED3
Euronext CAC 40 ESG Decr...
USOTC
ICPBQ
Inscape (GM)
BIT
P1IDE0
BNP Paribas Issuance
BIT
P1TBB7
BNP Paribas Issuance
COIN
FNSAEUR
Finschia
COIN
PIXEUST
Pixie
BIT
P1SXT5
BNP Paribas Issuance
NASDAQ
BOTZ
Global X Robotics & Arti...
BIT
P1PXO2
BNP Paribas Issuance
TG
9ZY
Algoma Steel
BIT
P1ORU4
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados